Lamisil and Hepatitis fulminant - a phase IV clinical study of FDA data

Summary:

Hepatitis fulminant is reported as a side effect among people who take Lamisil (terbinafine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Warfarin Sodium, and have Nail tinea.

The phase IV clinical study analyzes which people have Hepatitis fulminant when taking Lamisil. It is created by eHealthMe based on reports of 13,455 people who have side effects when taking Lamisil from the FDA, and is updated regularly.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

What is Hepatitis fulminant?

Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function) is found to be associated with 449 drugs and 677 conditions by eHealthMe. Check the latest studies of Hepatitis fulminant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

13,455 people reported to have side effects when taking Lamisil.
Among them, 18 people (0.13%) have Hepatitis fulminant.

Could Lamisil cause Hepatitis fulminant?

Among these 18 people:

How long have people been on Lamisil when they have Hepatitis fulminant? *

What is the gender of people who have Hepatitis fulminant when taking Lamisil? *

female: 18.75 %
male: 81.25 %

What is the age of people who have Hepatitis fulminant when taking Lamisil? *

What are other drugs people take besides Lamisil? *

Warfarin Sodium: 3 people, 16.67%
Vitamin B6: 1 person, 5.56%
Glivec: 1 person, 5.56%
Dothiepin Hydrochloride: 1 person, 5.56%
Digoxin: 1 person, 5.56%
Celestone: 1 person, 5.56%

What are other side effects people have besides Hepatitis fulminant? *

Hepatic Failure (liver failure): 7 people, 38.89%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 6 people, 33.33%
Depressed Level Of Consciousness: 5 people, 27.78%
Coma Hepatic (accumulation in the bloodstream of toxic substances that are normally removed by the liver leads coma): 5 people, 27.78%
Indigestion: 4 people, 22.22%
Blood Lactate Dehydrogenase Increased: 4 people, 22.22%
Blood Creatine Phosphokinase Increased: 4 people, 22.22%
Liver Function Test Abnormal: 4 people, 22.22%
Hyperbilirubinaemia (excess of bilirubin in the blood): 4 people, 22.22%
Acute Kidney Failure: 4 people, 22.22%

What are the existing conditions these people have? *

Nail Tinea (fungal infection of nail): 9 people, 50.00%
Athlete's Foot (a fungal infection affecting the skin between the toes): 3 people, 16.67%
Tinea Capitis (a fungal infection of the scalp): 1 person, 5.56%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 5.56%
High Blood Pressure: 1 person, 5.56%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 5.56%
Arrhythmias (irregular heartbeat): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lamisil and have Hepatitis fulminant?

- Check whether Hepatitis fulminant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamisil:

Lamisil (14,080 reports)

Browse all side effects of Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis fulminant:

Hepatitis fulminant (449 drugs)

Browse all the conditions that are associated with Hepatitis fulminant:

Hepatitis fulminant (677 conditions)

Related publications that referenced our studies

Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on terbinafine hydrochloride (the active ingredients of Lamisil) and Lamisil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.